Clinical

TORONTO | The Ontario Institute for Cancer Research is collaborating with pharmaceutical company Janssen to find and test new biomarkers to identify patients with hormone-resistant prostate cancer at high risk for disease progression and biomarkers of response to therapy.

MONTREAL | Laurent Pharmaceuticals, a start-up pharmaceutical company specializing in drug development for orphan diseases, has been created by MSBi Valorisation, McGill University and the Research Institute of the McGill University Health Centre.